Related Experiment Videos
Mortality of patients with renal dysfunction after percutaneous coronary intervention
Sebastjan Bevc1, Meta Penko, Vojko Kanic
1Clinic for Internal Medicine, Department of Nephrology, University Medical Center, Maribor, Slovenia. sebastjanb@yahoo.com
Insights
Renal dysfunction significantly increases mortality risk in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). Early identification and management of kidney disease are crucial for improving outcomes after PCI procedures.
Area of Science:
- Cardiology
- Nephrology
- Clinical Research
Background:
- Acute coronary syndrome (ACS) is a leading cause of cardiovascular mortality.
- Percutaneous coronary intervention (PCI) is a common revascularization strategy for ACS.
- Renal dysfunction is an underrecognized risk factor for adverse outcomes in cardiovascular disease.
Purpose of the Study:
- To investigate the association between stages of renal dysfunction and mortality in patients with ACS following PCI.
- To identify predictors of mortality in this high-risk population.
Main Methods:
- A cohort of 449 ACS patients undergoing PCI was analyzed.
- Renal function was assessed using serum creatinine and calculated creatinine clearance (MDRD formula).
- Kaplan-Meier survival analysis and adjusted Cox regression models were employed to evaluate mortality risk.
Main Results:
- Chronic kidney disease (CKD) prevalence (GFR <60 mL/min/1.73 m²) was 26.3%.
- Mortality risk increased progressively with higher stages of renal dysfunction (Stage 1-4).
- Independent predictors of mortality included gender, age, total cholesterol, and stage of renal dysfunction.
Conclusions:
- Advanced stages of renal dysfunction are directly associated with increased mortality in ACS patients post-PCI.
- Renal function status is a critical determinant of long-term survival after PCI for ACS.
- This study highlights the importance of considering renal impairment in risk stratification and management strategies for ACS patients.
Aim:
To determine the impact of stages of renal dysfunction on mortality after percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS).
Patients And Methods:
A total of 449 patients (mean age 63 +/- 11.9 years) with ACS after PCI were included. Serum creatinine was determined and creatinine clearance was calculated using the Modification of Diet in Renal Disease (MDRD) formula.
Results:
The prevalence of chronic kidney disease (CKD) defined as glomerular filtration rate (GFR) <60 mL/min per 1.73 m(2) was 26.3%. After up to 787 days of follow-up, 40 patients had died. Kaplan-Meier survival analysis showed progressively higher risk for cardiovascular death from stage 1 to stage 4 of renal dysfunction. In an adjusted Cox model, gender (P < .009), age (P < .0001), total cholesterol level (P < .01), and stage of renal dysfunction (P < .04) were predictors of mortality.
Conclusions:
In patients with ACS after PCI, a higher stage of renal dysfunction was directly associated with higher mortality of these patients.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury III: Clinical Manifestations
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury I: Introduction